Lupus nephritis and Swelling

Summary:

Swelling is found among people with Lupus nephritis, especially for people who are female, 20-29 old.

The study analyzes which people have Swelling with Lupus nephritis. It is created by eHealthMe based on reports of 63 people who have Lupus nephritis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Lupus nephritis?

Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue) is found to be associated with 166 drugs and 370 conditions by eHealthMe. Check the latest studies of Lupus nephritis.

What is Swelling?

Swelling is found to be associated with 2,300 drugs and 2,891 conditions by eHealthMe. Check the latest studies of Swelling.



On Jul, 10, 2026

63 people who have Lupus Nephritis and Swelling are studied.

Would you have Swelling when you have Lupus nephritis?

Gender of people who have Lupus Nephritis and experienced Swelling *:

  • female: 94.92 %
  • male: 5.08 %

Age of people who have Lupus Nephritis and experienced Swelling *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 5.26 %
  • 20-29: 34.21 %
  • 30-39: 15.79 %
  • 40-49: 23.68 %
  • 50-59: 18.42 %
  • 60+: 2.63 %

Common co-existing conditions for these people *:

  1. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 6 people, 9.52%
  2. Cough: 3 people, 4.76%
  3. High Blood Pressure: 3 people, 4.76%
  4. Lupus Encephalitis (a chronic inflammatory autoimmune disorder that may affect brain): 2 people, 3.17%
  5. Rhinovirus Infection: 2 people, 3.17%
  6. Hypercoagulation (increased tendency for clotting of the blood): 1 person, 1.59%
  7. Chronic Kidney Disease: 1 person, 1.59%
  8. Fever: 1 person, 1.59%
  9. Glomerular Vascular Disorder (disease primarily affecting the blood vessels of glomerular): 1 person, 1.59%
  10. Insomnia (sleeplessness): 1 person, 1.59%

Common drugs taken by these people *:

  1. Lupkynis: 49 people, 77.78%
  2. Prednisone: 12 people, 19.05%
  3. Mycophenolic Acid: 7 people, 11.11%
  4. Furosemide: 6 people, 9.52%
  5. Amlodipine: 5 people, 7.94%
  6. Cellcept: 4 people, 6.35%
  7. Myfortic: 4 people, 6.35%
  8. Benlysta: 4 people, 6.35%
  9. Keppra: 3 people, 4.76%
  10. Losartan: 3 people, 4.76%

Common symptoms for these people *:

  1. High Blood Pressure: 18 people, 28.57%
  2. Headache (pain in head): 14 people, 22.22%
  3. Pain: 11 people, 17.46%
  4. Fatigue (feeling of tiredness): 8 people, 12.70%
  5. Cough: 8 people, 12.70%
  6. Nausea (feeling of having an urge to vomit): 8 people, 12.70%
  7. Dyspnea (difficult or laboured breathing): 7 people, 11.11%
  8. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 7 people, 11.11%
  9. Hair Loss: 7 people, 11.11%
  10. Joint Pain: 6 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Swelling?

- Check whether Swelling is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Swelling:

All the conditions that are associated with Swelling:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Swelling and Lupus nephritis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: